Medicine & Life Sciences
4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-(2-aminocyclohexylamino)pyrimidine-5-carboxamide
12%
6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine
42%
Acute Myeloid Leukemia
10%
Agammaglobulinaemia Tyrosine Kinase
19%
B-Cell Chronic Lymphocytic Leukemia
100%
B-Cell Lymphoma
25%
B-Cell Prolymphocytic Leukemia
10%
B-Lymphocytes
26%
Bendamustine Hydrochloride
9%
BI 836826
13%
Bortezomib
11%
Central Nervous System
8%
Cladribine
24%
Colony-Stimulating Factor Receptors
8%
CPI203
12%
CPX-351
10%
Epigenomics
8%
idelalisib
45%
Lenalidomide
7%
Leukemia
7%
Lupus Coagulation Inhibitor
7%
Lymphoma
9%
Lymphoma, Large B-Cell, Diffuse
11%
Mantle-Cell Lymphoma
82%
Methotrexate
7%
Neoplasms
15%
Non-Hodgkin's Lymphoma
40%
obinutuzumab
18%
PCI 32765
73%
Peripheral T-Cell Lymphoma
7%
pevonedistat
9%
Pharmaceutical Preparations
9%
Phosphatidylinositol 3-Kinase
17%
Phospholipase C gamma
8%
Phosphotransferases
12%
Progression-Free Survival
14%
Prostatic Neoplasms
8%
Protein-Tyrosine Kinases
9%
Recurrence
8%
Rituximab
29%
Safety
9%
Signal Transduction
14%
Survival
19%
Syk Kinase
25%
Therapeutics
20%
Transplants
7%
TRU 016
23%
venetoclax
8%
Vorinostat
8%